Idaho Ballot Measure Would Lock Out Companies Looking to Legalize Weed
Idaho voters have spent 15 years squashing proposal after proposal to legalize marijuana. Now, this November, Idaho citizens will choose whether to give their elected representatives sole authority over state drug policy.
The proposed Grant Legislature Exclusive Authority and Prohibit Citizen-Initiated Measures on Marijuana, Narcotics and Psychoactive Substances Amendment (HJR 4) would remove citizens’ authority under the state Constitution to create ballot measures dictating drug policy.
Proponents of HJR 4, which passed the Idaho House and Senate in 58-10 and 29-6 votes, respectively, say it would insulate state from rich weed companies that fund marijuana legalization campaigns.
“The proposed constitutional amendment ensures that out-of-state weed barons are not able to hijack the Idaho ballot initiative process and legalize marijuana,” Blaine Conzatti, president of the Focus on the Family-allied Idaho Family Policy Center, told the Daily Citizen.
“The adoption of HJR 4 would reserve those decisions for the people of Idaho acting through their elected representatives.”
The organization recommends citizens votes “Yes” on the proposed amendment.
Idahoans are already familiar with marijuana industry pressures. A measure to legalize medical marijuana has been proposed in every Idaho state election since 2012. In 2022, a measure to legalize the recreational use and sale of marijuana was floated.
But, in 15 years, no marijuana legalization campaign has ever gathered enough signatures to get a proposed measure on the ballot — likely because Idaho’s citizens understand marijuana devastates people physically and mentally.
A comprehensive UCLA analysis of marijuana research published between January 2010 and September 2025 found the drug successfully treats only three medical conditions:
- Appetite loss caused by HIV/AIDS.
- Nausea and vomiting caused by chemotherapy.
- Some pediatric seizure disorders.
Beyond these illnesses, researchers concluded evidence “does not support the use of cannabis or cannabinoids for most conditions for which it is promoted, such as acute pain or insomnia.”
In fact, the same study connected daily, high-potency marijuana use to higher rates of heart disease and greater risk of stroke.
Prolonged marijuana use can also lead to cannabinoid hyperemesis syndrome (CHS), a condition causing debilitating nausea and vomiting that can be fatal if left untreated.
Decades of research links marijuana consumption to the development of psychosis and serious mental illness. As the Daily Citizen previously reported:
- People who smoke high-THC marijuana daily are five times as likely to develop a psychotic disorder than those who don’t smoke (The Lancet; 2019).
- As many as one in 200 individuals who ingest marijuana experience cannabis-associated psychotic symptoms (Nature; 2024).
- A cannabis-induced psychotic episode has a 47% chance of triggering schizophrenia or bipolar disorder — a higher likelihood than psychotic episodes induced by alcohol, opioids, sedatives, cocaine and amphetamines (American Journal of Psychiatry; 2017).
Adolescents face an even higher probability of developing serious mental health problems after ingesting marijuana. A recent study of nearly 500,000 teens between 13 and 17 years old found those who ingested marijuana, no matter how much, were more than twice as likely as their peers to develop bipolar or psychotic disorder by the time they turned 26.
States which legalize marijuana also tend to experience unintended ripple effects — like skyrocketing rates of pediatric exposure to marijuana.
A year after Ohio legalized marijuana in 2023, nearly 600 children five years old or younger were admitted to hospitals after ingesting the drug — a more than 1,100% increase from 2018, when hospitals first started keeping track.
The children reportedly experienced symptoms including breathing problems, problems with their central nervous systems, vomiting, hallucinations and seizures.
But HJR 4 protects Idaho citizens from more than just marijuana. The proposed constitutional amendment would also prevent citizens from changing laws around narcotics and psychoactive substances.
“Idaho residents watched as our neighboring state of Oregon decriminalized illicit drugs through a ballot initiative and immediately saw an explosion in violent crimes, property crime and moral decline,” Conzatti told the Daily Citizen.
“Adopting HJR 4 ensures that Idaho will not experience the same fate.”
Oregon Governor Tina Kotek signed House Bill 4002, which recriminalized the possession of meth, fentanyl and other hard drugs, on April 1, 2024.
The law undid changes made by Measure 110, a ballot initiative which made having and using hard drugs punishable by a mere $100 fine. The measure made Portland “a homeless drug addict’s slice of paradise,” one homeless person told The New York Times in July 2023.
The Idaho state Constitution states “the first concern of all good government is the virtue and sobriety of the people, and the purity of the home … [and] for the promotion of temperance and morality.”
But Idaho representatives cannot fulfill this charge if drug companies with deep pockets and other radical interests seek to use citizen-led ballot initiatives to change Idaho’s drug policy.
“The Idaho legislature takes seriously this constitutional charge and has consistently restricted access to harmful psychoactive substances like marijuana,” Conzatti concludes.
“Decriminalizing or further restricting drug use should remain he prerogative of the state legislature.”
If you live in Idaho, please consider voting “Yes” this November 3 on HJR 4, the Grant Legislature Exclusive Authority and Prohibit Citizen-Initiated Measures on Marijuana, Narcotics and Psychoactive Substances Amendment.
Readers in other states, please educate your children about the harmful effects of marijuana and chemically-altered hemp products. Click on the articles below to learn more.
Additional Articles and Resources
Oregon Lawmakers Vote to Recriminalize Hard Drugs
Senate Waffles on Banning Hemp-Derived THC
ABOUT THE AUTHOR
